市场调查报告书
商品编码
1467612
2024-2032 年医疗保健市场 3D 列印材料、技术(液滴沉积、光聚合、雷射光束熔化、电子束熔化、层压物体製造等)、应用、最终用户和地区报告3D Printing in Healthcare Market Report by Material,Technology (Droplet Deposition, Photopolymerization, Laser Beam Melting, Electronic Beam Melting, Laminated Object Manufacturing, and Others), Application, End User, and Region 2024-2032 |
IMARC Group年,全球医疗保健3D列印市场规模达30亿美元。与影像技术的日益融合、3D 列印公司和医疗机构之间不断加强的合作、器官和组织列印潜力的不断增长以及桌面 3D 列印机的便利性是推动市场发展的一些因素。
在医疗保健领域,三维 (3D) 列印已成为一种具有多种应用的变革性技术。这项尖端技术透过促进外科切割工具、钻导板和义肢的开发,正在彻底改变这个领域。此外,它还可以製作针对患者的骨骼、器官和血管的复製品,从而促进精确的手术计划和培训。此外,3D 列印在再生医学和组织工程中发挥重要作用,可以创造活的人体细胞和组织。这项突破为客製化医疗解决方案铺平了道路,从客製化义肢到针对患者的药物配方和设备改造。其主要优势之一在于降低复杂手术过程中的手术风险,最大限度地减少感染的可能性,并限制麻醉暴露的持续时间。这不仅提高了患者的安全,也加快了康復速度。此外,3D 列印有助于节省时间和成本,简化医疗流程并确保更有效地提供医疗服务。因此,这项技术在全球医疗保健产业中获得了巨大的关注,为创新和个人化照护提供了前所未有的可能性。正如我们所知,它具有改变医疗保健的潜力,证明了医疗技术的不断进步。
全球市场主要受到 3D 列印技术不断进步的推动。与此一致的是,医疗设备和植入物的定制以及医学研究的快速原型设计正在为市场做出巨大贡献。此外,复杂解剖模型的经济高效生产正在对市场产生积极影响。除此之外,对患者专用手术导板的需求不断增长以及慢性病盛行率的不断上升正在催化市场。此外,老年人口的不断增加以及药物开发和测试的加速正在推动市场的发展。此外,加强手术规划和培训正在增强市场。义肢和矫形外科应用的增加以及生物相容性材料产量的增加正在推动市场的发展。此外,对医疗 3D 列印的监管支援以及医疗保健专业人员日益增强的意识也为市场提供了推动力。
对再生药物、干细胞解决方案和癌症治疗的需求不断增加
对再生药物、干细胞解决方案和癌症治疗的需求不断增长,正在提振市场。再生医学依赖精确的组织工程和器官复製,而 3D 列印在这方面表现出色。使用生物相容性材料创建患者特异性结构的能力与再生医学的目标完美契合,为需要组织替换或再生的人带来了希望。此外,通常用于个人化治疗方法的干细胞解决方案受益于 3D 列印在创建支持细胞生长和分化的客製化支架和结构方面的精确性。此外,癌症疗法的开发越来越多地涉及模拟肿瘤环境的 3D 列印模型。这些模型有助于药物测试,最终导致更有效和客製化的癌症治疗。
研发 (R&D) 活动投资不断增加
不断增加的研发 (R&D) 投资创造了积极的市场前景。研发投资通常会导致尖端技术和创新的发展,从而彻底改变产业。它使公司能够创造新的和改进的产品,保持竞争力,并满足不断变化的客户需求。研究工作可以提高生产流程的效率,降低成本和资源消耗。它可以帮助公司开拓新市场、扩大产品范围并涵盖更广泛的客户群。它还可以促进环保技术和实践的发展,解决环境问题。研发资金推动医疗保健领域的医学发现,从而带来新的治疗方法、药物和疗法。强大的研发生态系统可以透过创造就业、促进创新和吸引投资来刺激经济成长。
扩大医药应用
3D 列印在製药领域的不断扩大应用正在推动医疗保健市场的显着成长。这项变革因素透过允许药物的精确定製而彻底改变了药物开发和交付。透过 3D 列印,可以定製药物以满足患者的个别需求,从而实现更有效的治疗并改善患者的治疗效果。此外,3D列印有助于创建复杂的药物输送系统,实现控制释放并提高药物疗效。该技术能够快速製作新药物配方原型,从而加速药物开发,并减少时间和成本。此外,透过 3D 列印,儿科药物和罕见疾病专用药物的生产变得更加可行且更具成本效益。随着监管机构适应这些创新,医疗保健产业正在见证药品生产和患者护理的根本性转变,推动市场大幅成长,并有望在未来提供更个人化和高效的医疗保健解决方案。
The global 3D printing in healthcare market size reached US$ 3.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.4 Billion by 2032, exhibiting a growth rate (CAGR) of 13.2% during 2024-2032. The increasing integration with imaging technologies, the rising collaborations between 3D printing companies and healthcare institutions, the growing potential for organ and tissue printing, and the easy accessibility of desktop 3D printers are some of the factors propelling the market.
In healthcare, three-dimensional (3D) printing has emerged as a transformative technology with diverse applications. This cutting-edge technology is revolutionizing the field by enabling the development of surgical cutting tools, drill guides, and prosthetics. Additionally, it can craft patient-specific replicas of bones, organs, and blood vessels, facilitating precise surgical planning and training. Moreover, 3D printing is instrumental in regenerative medicine and tissue engineering, where it can create living human cells and tissues. This breakthrough paves the way for customized medical solutions, from tailored prosthetics to patient-specific drug formulations and equipment adaptations. One of its key advantages lies in reducing operative risks during intricate procedures, minimizing the likelihood of infections, and limiting the duration of anesthesia exposure. This not only enhances patient safety but also expedites recovery. Furthermore, 3D printing contributes to time and cost savings, streamlining the healthcare process and ensuring more efficient delivery of medical services. As a result, this technology is gaining remarkable traction across the global healthcare industry, offering unprecedented possibilities for innovation and personalized care. Its potential to transform healthcare as we know it is a testament to the ongoing advancements in medical technology.
The global market is majorly driven by the increasing advancements in 3D printing technology. In line with this, the customization of medical devices and implants and the rapid prototyping for medical research are significantly contributing to the market. Furthermore, the cost-effective production of complex anatomical models is positively influencing the market. Apart from this, the rising demand for patient-specific surgical guides and the growing prevalence of chronic diseases are catalyzing the market. Moreover, the escalating elderly population and the accelerating drug development and testing are propelling the market. Besides, enhanced surgical planning and training are strengthening the market. The increasing prosthetics and orthopedic applications and the rising production of biocompatible materials are fueling the market. Additionally, the regulatory support for medical 3D printing and the growing awareness among healthcare professionals are providing a boost to the market.
Increasing need for regenerative medicines, stem cell solutions, and cancer therapeutics
The increasing need for regenerative medicines, stem cell solutions, and cancer therapeutics is bolstering the market. Regenerative medicine relies on precise tissue engineering and organ replication, where 3D printing excels. The ability to create patient-specific constructs with biocompatible materials aligns perfectly with regenerative medicine's goals, offering hope for those in need of tissue replacement or regeneration. Furthermore, stem cell solutions, often used for personalized treatment approaches, benefit from 3D printing's precision in creating custom scaffolds and structures that support cell growth and differentiation. Moreover, the development of cancer therapeutics increasingly involves 3D-printed models to mimic tumor environments. These models aid drug testing, ultimately leading to more effective and tailored cancer treatments.
Rising investments in research and development (R&D) activities
Rising research and development (R&D) investments create a positive market outlook. Investment in R&D often results in the development of cutting-edge technologies and innovations that can revolutionize industries. It allows companies to create new and improved products, stay competitive, and meet evolving customer demands. Research efforts can lead to more efficient production processes, reducing costs and resource consumption. It can help companies explore new markets, expand their product offerings, and reach a broader customer base. It can also lead to the development of eco-friendly technologies and practices, addressing environmental concerns. R&D funding drives medical discoveries in healthcare, leading to new treatments, drugs, and therapies. A robust R&D ecosystem can stimulate economic growth by creating jobs, fostering innovation, and attracting investment.
Expanding pharmaceutical applications
The expanding pharmaceutical applications of 3D printing are propelling significant growth in the healthcare market. This transformative factor is revolutionizing drug development and delivery by allowing for the precise customization of pharmaceuticals. With 3D printing, medications can be tailored to meet individual patient needs, resulting in more effective treatments and enhanced patient outcomes. Moreover, 3D printing facilitates the creation of complex drug delivery systems, enabling controlled release and improved drug efficacy. The technology's ability to rapidly prototype new drug formulations accelerates drug development, reducing time and costs. Additionally, the production of pediatric medications and specialized drugs for rare diseases is made more feasible and cost-effective through 3D printing. As regulatory bodies adapt to accommodate these innovations, the healthcare industry is witnessing a fundamental shift in pharmaceutical production and patient care, driving substantial market growth and promising a future of more personalized and efficient healthcare solutions.
IMARC Group provides an analysis of the key trends in each segment of the global 3D printing in healthcare market report, along with forecasts at the global, regional and country levels for 2024-2032. Our report has categorized the market based on material, technology, application, and end user.
Polymer
Metals
Ceramic
Organic
Polymer dominates the market
The report has provided a detailed breakup and analysis of the market based on the material. This includes polymer, metals, ceramic, and organic. According to the report, polymer represented the largest segment.
Polymer-based 3D printing is instrumental in creating various medical devices, prosthetics, and customized implants. Biocompatible polymers like PLA and PEEK are widely used in creating patient-specific anatomical models and dental applications. Moreover, they are suitable materials for cost-effective prosthetic limbs and orthopedic implants, enhancing patient mobility and comfort.
On the other hand, metal 3D printing is revolutionizing the production of intricate and durable medical components. Titanium and stainless steel alloys are commonly employed in manufacturing orthopedic implants, cranial implants, and dental prosthetics. These metals offer exceptional strength and biocompatibility, ensuring the longevity and reliability of implanted devices. Additionally, metal 3D printing's precision allows for intricate lattice structures that promote osseointegration, enabling faster healing and improved patient outcomes.
Droplet Deposition
Fused Filament Fabrication (FFF) Technology
Low-temperature Deposition Manufacturing (LDM)
Multiphase Jet Solidification (MJS)
Photopolymerization
Stereolithography (SLA)
Continuous Liquid Interface Production (CLIP)
Two-photon Polymerization (2PP)
Laser Beam Melting
Selective Laser Sintering (SLS)
Selective Laser Melting (SLM)
Direct Metal Laser Sintering (DMLS)
Electronic Beam Melting (EBM)
Laminated Object Manufacturing
Others
Droplet deposition dominates the market
The report has provided a detailed breakup and analysis of the market based on the technology. This includes droplet deposition (fused filament fabrication (FFF) technology, low-temperature deposition manufacturing (LDM), multiphase jet solidification (MJS)), photopolymerization (stereolithography (SLA), continuous liquid interface production (CLIP), two-photon polymerization (2PP)), laser beam melting (selective laser sintering (SLS), selective laser melting (SLM), direct metal laser sintering (DMLS)), electronic beam melting (EBM), laminated object manufacturing, and others. According to the report, droplet deposition represented the largest segment.
Droplet Deposition technology, also known as Fused Deposition Modeling (FDM), is cost-effective and widely used for producing patient-specific anatomical models, custom prosthetics, and orthopedic implants. It offers versatility and accessibility, making it suitable for various healthcare applications, including educational purposes.
On the other hand, utilizing photoreactive polymers, photopolymerization, exemplified by stereolithography (SLA) and Digital Light Processing (DLP), excels in creating highly detailed and intricate medical models and dental devices. It enables the production of accurate prototypes, dental crowns, and surgical guides, supporting precise and personalized healthcare solutions.
Moreover, laser-based technologies like Selective Laser Sintering (SLS) and Direct Metal Laser Sintering (DMLS) are vital for manufacturing complex metal components such as orthopedic implants, prosthetics, and dental restorations. The exceptional accuracy and material strength provided by laser beam melting is essential for critical medical applications, ensuring durability and biocompatibility.
External Wearable Devices
Hearing Aids
Prosthesis and Orthotics
Dental Products
Clinical Study Devices
Drug Testing
Anatomical Models
Implants
Surgical Guides
Cranio-maxillofacial Implants
Orthopedic Implants
Tissue Engineering
External Wearable Devices dominates the market
The report has provided a detailed breakup and analysis of the market based on the application. This includes external wearable devices (hearing aids, prosthesis and orthotics, dental products), clinical study devices (drug testing and anatomical models), implants (surgical guides, cranio-maxillofacial implants, and orthopedic implants), and tissue engineering. According to the report, external wearable devices represented the largest segment.
3D printing technology facilitates the production of custom-fit external wearable devices such as prosthetic limbs, orthopedic braces, and hearing aids. These personalized devices enhance patient comfort, mobility, and quality of life, driving growth in this segment.
On the contrary, 3D printing creates patient-specific models, surgical guides, and anatomical replicas in medical research and clinical trials. These devices are instrumental in enhancing surgical training, medical education, and preoperative planning, thus contributing to the growth of this segment.
Moreover, the production of implants, including orthopedic, dental, and cranial implants, is a critical application of 3D printing in healthcare. These patient-specific implants offer improved functionality, durability, and biocompatibility, driving significant growth in the market.
Medical and Surgical Centers
Pharmaceutical and Biotechnology Companies
Academic Institutions
Medical and surgical centers dominates the market
The report has provided a detailed breakup and analysis of the market based on the end user. This includes medical and surgical centers, pharmaceutical and biotechnology companies, and academic institutions. According to the report, medical and surgical centers represented the largest segment.
Medical and surgical centers include hospitals, clinics, and specialized healthcare facilities. These institutions widely utilize 3D printing for applications such as patient-specific anatomical models, surgical guides, custom prosthetics, and orthopedic implants. The technology empowers healthcare providers with tools for precise diagnosis, treatment planning, and patient-specific interventions, enhancing overall patient care and surgical outcomes. The growing adoption of 3D printing in medical and surgical centers drives market growth by improving healthcare delivery.
Furthermore, the pharmaceutical and biotechnology sector leverages 3D printing for drug development, personalized medicine, and drug delivery systems. 3D-printed pills, tablets, and drug-loaded implants enable precise dosing, improved drug release profiles, and customized therapies. This segment fosters market growth by advancing drug development processes and enhancing the efficacy and safety of pharmaceutical products.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance, accounting for the largest market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America, encompassing the United States and Canada, is a significant driver of growth in 3D printing in healthcare market due to several key factors. It is a hub for technological advancements and innovation, fostering the development and adoption of 3D printing in healthcare applications. The region boasts advanced healthcare facilities and research institutions that actively utilize 3D printing for patient-specific models, surgical planning, and medical device production. Regulatory bodies in North America have been receptive to 3D printing technologies in healthcare, expediting approvals for medical devices and implants.
Ongoing investment in research and development activities fuels continuous innovation and growth in 3D printing applications, benefiting both the medical and pharmaceutical sectors. The region is home to leading 3D printing companies and healthcare providers that drive market growth through collaborations and investments in cutting-edge technologies. Furthermore, patients increasingly seek personalized healthcare solutions, escalating the adoption of 3D printing for customized implants, prosthetics, and medical models.
Top companies are strengthening the market growth through their innovative approaches and unwavering commitment to advancing medical technology. These industry leaders are contributing to growth in several key ways. They are at the forefront of research and development, investing heavily in cutting-edge technologies that enhance the capabilities of 3D printing in healthcare. These innovations expand the scope of applications, from patient-specific implants to drug delivery systems. Top companies actively collaborate with healthcare institutions and research organizations to drive progress. These collaborations result in groundbreaking solutions and foster a deeper understanding of 3D printing's potential in medicine. They work closely with regulatory authorities to ensure compliance with evolving healthcare standards, facilitating the adoption of 3D-printed medical devices and pharmaceuticals. These companies invest in educational initiatives to train healthcare professionals to use 3D printing technology effectively. They contribute to global awareness, demonstrating the transformative impact of 3D printing in healthcare through case studies and success stories. Their dedication to pushing the boundaries of what's possible in the medical field ensures the continued growth and evolution of 3D printing in healthcare market.
The report has provided a comprehensive analysis of the competitive landscape of 3D printing in healthcare market. Detailed profiles of all major companies have also been provided.
3D Systems Inc.
Desktop Metal Inc.
EOS GmbH
Formlabs
Materialise NV
Organovo Holding Inc.
Oxford Performance Materials Inc.
Prodways Tech
Proto Labs Inc.
Renishaw plc
SLM Solutions Group AG
Stratasys Ltd
In August 2023, 3D Systems, a prominent player in additive manufacturing solutions, and Theradaptive, a biopharmaceutical innovator specializing in targeted regenerative therapies, unveiled a commercial agreement. This partnership designates 3D Systems as the exclusive 3D printing collaborator for Theradaptive. Together, they are poised to introduce an innovative approach to stimulate bone and tissue growth.
In July 2023, Desktop Health forged a strategic partnership with Carbon to introduce the Flexcera Family Resins to the Carbon Digital Manufacturing Platform. This collaboration represents a significant development in digital manufacturing and dental technology.
In June 2023, EOS GmbH partnered with Tecomet, Inc., Precision ADM, and OIC to provide end-to-end medical device additive manufacturing solutions.